Virtus Investment Advisers, Inc. Neurocrine Biosciences Inc Transaction History
Virtus Investment Advisers, Inc.
- $286 Million
- Q2 2025
A detailed history of Virtus Investment Advisers, Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 3,555 shares of NBIX stock, worth $509,111. This represents 0.16% of its overall portfolio holdings.
Number of Shares
3,555
Previous 2,833
25.49%
Holding current value
$509,111
Previous $313,000
42.49%
% of portfolio
0.16%
Previous 0.11%
Shares
4 transactions
Others Institutions Holding NBIX
# of Institutions
683Shares Held
102MCall Options Held
290KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$2.03 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$1.4 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$797 Million0.42% of portfolio
-
State Street Corp Boston, MA4.47MShares$640 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$442 Million0.04% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.7B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...